CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma

Cancer Genome Atlas Research N. , Integrated genomic characterization of papillary thyroid carcinoma, Cell 159 (2014), 676-90.

Howell G.M. , Nikiforova M.N. , Carty S.E. , Armstrong M.J. , Hodak S.P. , Stang M.T. , McCoy K.L. , Nikiforov Y.E. and Yip L. , BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer, Ann Surg Oncol 20 (2013), 47-52.

Halkova T. , Dvorakova S. , Sykorova V. , Vaclavikova E. , Vcelak J. , Vlcek P. , Sykorova P. , Kodetova D. , Betka J. , Lastuvka P. , Bavor P. , Hoch J. , Katra R. and Bendlova B. , Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma, Cancer Biomark 17 (2016), 97-106.

Sipos J.A. and Mazzaferri E.L. , Thyroid cancer epidemiology and prognostic variables, Clin Oncol (R Coll Radiol) 22 (2010), 395-404.

Cheng S. , Serra S. , Mercado M. , Ezzat S. and Asa S.L. , A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior, Clin Cancer Res 17 (2011), 2385-94.

Sun M. , Fang S. , Li W. , Li C. , Wang L. , Wang F. and Wang Y. , Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma, Cancer Biomark 15 (2015), 33-40.

Abd El-Fattah A.A. , Sadik N.A. , Shaker O.G. and Kamal A.M. , Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?, Tumour Biol (2016).

Libreros S. and Iragavarapu-Charyulu V. , YKL-40/CHI3L1 drives inflammation on the road of tumor progression, J Leukoc Biol 98 (2015), 931-6.

Shao R. , Hamel K. , Petersen L. , Cao Q.J. , Arenas R.B. , Bigelow C. , Bentley B. and Yan W. , YKL-40, a secreted glycoprotein, promotes tumor angiogenesis, Oncogene 28 (2009), 4456-68.

Liu X. , Zhang Y. , Zhu Z. , Ha M. and Wang Y. , Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer, Med Oncol 31 (2014), 85.

Shao R. , Cao Q.J. , Arenas R.B. , Bigelow C. , Bentley B. and Yan W. , Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers, Br J Cancer 105 (2011), 1203-9.

Xu C.H. , Yu L.K. and Hao K.K. , Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer, PLoS One 9 (2014), e96384.

Wang X.W. , Cai C.L. , Xu J.M. , Jin H. and Xu Z.Y. , Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis, Tumour Biol 36 (2015), 901-7.

Kucur M. , Isman F.K. , Balci C. , Onal B. , Hacibekiroglu M. , Ozkan F. and Ozkan A. , Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia, Urol Oncol 26 (2008), 47-52.

Ozdemir E. , Cicek T. and Kaya M.O. , Association of serum YKL-40 level with tumor burden and metastatic stage of prostate cancer, Urol J 9 (2012), 568-73.

Zhu C.B. , Wang C. , Chen L.L. , Ma G.L. , Zhang S.C. , Su L. , Tian J.J. and Gai Z.T. , Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma, PLoS One 7 (2012), e44648.

Zhu C.B. , Chen L.L. , Tian J.J. , Su L. , Wang C. , Gai Z.T. , Du W.J. and Ma G.L. , Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery, Ann Surg Oncol 19 (2012), 817-25.

Pelloski C.E. , Mahajan A. , Maor M. , Chang E.L. , Woo S. , Gilbert M. , Colman H. , Yang H. , Ledoux A. , Blair H. , Passe S. , Jenkins R.B. and Aldape K.D. , YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma, Clin Cancer Res 11 (2005), 3326-34.

Shao R. , Taylor S.L. , Oh D.S. and Schwartz L.M. , Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization, Oncotarget 6 (2015), 40507-18.

Krogh M. , Christensen I. , Bouwhuis M. , Johansen J.S. , Norgaard P. , Schmidt H. , Hansson J. , Suciu S. , Eggermont A.M. , Bastholt L. , Nordic Melanoma G. and Group E.M. , Prognostic and predictive value of YKL-40 in stage IIB-III melanoma, Melanoma Res (2016).

Schmidt H. , Johansen J.S. , Gehl J. , Geertsen P.F. , Fode K. and von der Maase H. , Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma, Cancer 106 (2006), 1130-9.

Schmidt H. , Johansen J.S. , Sjoegren P. , Christensen I.J. , Sorensen B.S. , Fode K. , Larsen J. and von der Maase H. , Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma, J Clin Oncol 24 (2006), 798-804.

Ma B. , Herzog E.L. , Lee C.G. , Peng X. , Lee C.M. , Chen X. , Rockwell S. , Koo J.S. , Kluger H. , Herbst R.S. , Sznol M. and Elias J.A. , Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis, Cancer Res 75 (2015), 487-96.

Roslind A. , Johansen J.S. , Christensen I.J. , Kiss K. , Balslev E. , Nielsen D.L. , Bentzen J. , Price P.A. and Andersen E. , High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival, Int J Cancer 122 (2008), 857-63.

Chiang Y.C. , Lin H.W. , Chang C.F. , Chang M.C. , Fu C.F. , Chen T.C. , Hsieh S.F. , Chen C.A. and Cheng W.F. , Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma, Oncotarget 6 (2015), 39740-55.

Peng C. , Peng J. , Jiang L. , You Q. , Zheng J. and Ning X. , YKL-40 protein levels and clinical outcome of human endometrial cancer J Int Med Res 38 (2010), 1448-57.

Fan J.T. , Li M.J. , Shen P. , Xu H. , Li D.H. and Yan H.Q. , Serum and tissue level of YKL-40 in endometrial cancer, Eur J Gynaecol Oncol 35 (2014), 304-8.

Jeet V. , Tevz G. , Lehman M. , Hollier B. and Nelson C. , Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells, Endocr Relat Cancer 21 (2014), 723-37.

Ku B.M. , Lee Y.K. , Ryu J. , Jeong J.Y. , Choi J. , Eun K.M. , Shin H.Y. , Kim D.G. , Hwang E.M. , Yoo J.C. , Park J.Y. , Roh G.S. , Kim H.J. , Cho G.J. , Choi W.S. , Paek S.H. and Kang S.S. , CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells, Int J Cancer 128 (2011), 1316-26.

Jefri M. , Huang Y.N. , Huang W.C. , Tai C.S. and Chen W.L. , YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer, BMC Cancer 15 (2015), 590.

Li J. , Guan H.Y. , Gong L.Y. , Song L.B. , Zhang N. , Wu J. , Yuan J. , Zheng Y.J. , Huang Z.S. and Li M. , Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival, Clin Cancer Res 14 (2008), 6996-7003.

Thom I. , Andritzky B. , Schuch G. , Burkholder I. , Edler L. , Johansen J.S. , Bokemeyer C. , Schumacher U. and Laack E. , Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer, Cancer 116 (2010), 4114-21.

Pollard J.W. , Tumour-educated macrophages promote tumour progression and metastasis, Nat Rev Cancer 4 (2004), 71-8.

Lin E.Y. and Pollard J.W. , Role of infiltrated leucocytes in tumour growth and spread, Br J Cancer 90 (2004), 2053-8.

Mantovani A. , Allavena P. and Sica A. , Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression, Eur J Cancer 40 (2004), 1660-7.

Su S. , Liu Q. , Chen J. , Chen J. , Chen F. , He C. , Huang D. , Wu W. , Lin L. , Huang W. , Zhang J. , Cui X. , Zheng F. , Li H. , Yao H. , Su F. and Song E. , A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis, Cancer Cell 25 (2014), 605-20.

Rehli M. , Niller H.H. , Ammon C. , Langmann S. , Schwarzfischer L. , Andreesen R. and Krause S.W. , Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation, J Biol Chem 278 (2003), 44058-67.

Volck B. , Price P.A. , Johansen J.S. , Sorensen O. , Benfield T.L. , Nielsen H.J. , Calafat J. and Borregaard N. , YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils, Proc Assoc Am Physicians 110 (1998), 351-60.

Johansen J.S. , Bojesen S.E. , Mylin A.K. , Frikke-Schmidt R. , Price P.A. and Nordestgaard B.G. , Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population, J Clin Oncol 27 (2009), 572-8.

Kawada M. , Seno H. , Kanda K. , Nakanishi Y. , Akitake R. , Komekado H. , Kawada K. , Sakai Y. , Mizoguchi E. and Chiba T. , Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer, Oncogene 31 (2012), 3111-23.

Libreros S. , Garcia-Areas R. , Shibata Y. , Carrio R. , Torroella-Kouri M. and Iragavarapu-Charyulu V. , Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model, Int J Cancer 131 (2012), 377-86.

Huang Y. , Prasad M. , Lemon W.J. , Hampel H. , Wright F.A. , Kornacker K. , LiVolsi V. , Frankel W. , Kloos R.T. , Eng C. , Pellegata N.S. and de la Chapelle A. , Gene expression in papillary thyroid carcinoma reveals highly consistent profiles, Proc Natl Acad Sci U S A 98 (2001), 15044-9.

Harving M.L. , Christensen L.H. , Ringsholt M. , Lausten G.S. and Petersen M.M. , YKL-40 expression in soft-tissue sarcomas and atypical lipomatous tumors. An immunohistochemical study of 49 tumors, Acta Orthop 85 (2014), 195-200.

Castellano I. , Mistrangelo M. , Crudo V. , Chiusa L. , Lupo R. , Ricardi U. , Morino M. , Mussa A. and Cassoni P. , YKL-40 expression in anal carcinoma predicts shorter overall and disease-free survival, Histopathology 55 (2009), 238-40.

Wang J. , Sheng Z. , Yang W. and Cai Y. , Elevated Serum Concentration of Chitinase 3-Like 1 is an Independent Prognostic Biomarker for Poor Survival in Lung Cancer Patients, Cell Physiol Biochem 38 (2016), 461-8.

Choudhuri S. , Sharma C. , Banerjee A. , Kumar S. , Kumar L. and Singh N. , A repertoire of biomarkers helps in detection and assessment of therapeutic response in epithelial ovarian cancer, Mol Cell Biochem 386 (2014), 259-69.